Open Access
The use of myosalvarsan in infants
Author(s) -
А. Дмитриев
Publication year - 2021
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj80563
Subject(s) - syphilis , medicine , weakness , pediatrics , congenital syphilis , surgery , human immunodeficiency virus (hiv) , virology
Waldeyer (Derm. Ztschr. Bd. 56, H. 5, 29), given that it is often impossible for infants to use Neo preparations intravenously, tried intramuscular injections of myosalvarsan in the treatment of 27 syphilitic children. The dose, depending on the age, weight and constitution of the patient, was dissolved in minimal amounts of destil. water, and injections were made every 5-8 days of treatment; a total of 12-15 injections were made during the course. Three children out of 27 died (11.2%) and a. He sees the cause of death not in the drug, but in the weakness of children with congenital syphilis, who usually die from extraneous infections. Based on his observations, the author believes that in myosalvarsan we have a remedy that is not irritating and does not have side effects. The use is very simple. When properly dosed, it should be included in the anti-syphilitic arsenal in the treatment of lues in infants.